-
Recent Posts
- Keto-Mojo Blogs About Stanton Migraine Protocol December 2, 2019
- Bad Science & Social Media Chatter November 27, 2019
- Why We Can’t Beat The Vegans To It October 30, 2019
- Children in Ketosis: The Feared Fuel October 12, 2019
- Where is the Beef? The 6 Papers That Turned the World Up-Side-Down October 1, 2019
Articles
- Follow Clueless Doctors & Scientists on WordPress.com
Follow me on Twitter
My TweetsAngela A. Stanton Ph.D.
Blogs I Follow
- Jimmy Lee
- FOODMED.NET
- Richard David Feinman
- Reflections of a Violinist
- Stanton Migraine Diet®
- HeartSphere
- My Carb Breakup
- The menopause histamine connection
- UndeniablySara
- Undiagnosed Warrior
- LOUISE FOWLER SPEAKS UP
- Disrupted Physician
- Simple Living Over 50
- Da UGLY Ducklin -IN DA LIFE OF PASSION
- dagmarhelbigart
- Stanton Migraine Protocol
- People-triggers
- rinspre01's Blog
- Montony with Style
- Fighting the Migraine Epidemic
Blog Stats
- 150,820 hits
Tag Archives: brand name
Big Win over The Medical Industry Today!
New information (now two) on the bottom! I know many of you are very frustrated with the medical industry in general. I have been–and still am as well–hence this blog. There have been many little victories and some I cannot … Continue reading
Posted in Interesting reading, Must Read, This & That, Thoughts
Tagged asthmam, brand name, brand name drugs, drug, generic, generic drugs, Merk, Merk Pharmaceuticals, Montelukast, Montelukast Sodium
6 Comments
Medication: Brand Name then Brand Name and then Brand Name again!
You are probably familiar with the patent length of new drugs but in case you are not, it is 20 years. What happens when the patent expires? You think you know the answer since you see so many generics and … Continue reading
Posted in Interesting reading, Must Read, This & That, Thoughts
Tagged abuse, big pharma, brand, brand name, bribes, corruption, crime, doctors, drug, drugs, expire, fight, fraud, generic, generic drug, generic drugs, health, illness, intent to hurt, lies, medicine, patent, pharma, pharmaceutical, politics
5 Comments